Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Histone-lysine N-methyltransferase, H3 lysine-79 specific [1-416] | ||
Ligand | BDBM244796 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | In Vitro Biological Assay | ||
IC50 | 0.8±n/a nM | ||
Citation | Klaus, C; Raimondi, MA; Daigle, SR; Pollock, RM Combination therapy for treating cancer US Patent US9446064 Publication Date 9/20/2016 | ||
More Info.: | Get all data from this article, Assay Method | ||
Histone-lysine N-methyltransferase, H3 lysine-79 specific [1-416] | |||
Name: | Histone-lysine N-methyltransferase, H3 lysine-79 specific [1-416] | ||
Synonyms: | DOT1L | DOT1L_HUMAN | Histone H3-K79 methyltransferase (DOT1L) | KIAA1814 | KMT4 | ||
Type: | Protein | ||
Mol. Mass.: | 47443.16 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q8TEK3 aa 1-416 | ||
Residue: | 416 | ||
Sequence: |
| ||
BDBM244796 | |||
n/a | |||
Name | BDBM244796 | ||
Synonyms: | US9446064, A87 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H34F3N7O4 | ||
Mol. Mass. | 589.6093 | ||
SMILES | CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc2c(N)ncnc12)[C@@H]1C[C@H](CCc2nc3cc(OC(F)(F)F)ccc3[nH]2)C1 |r,wU:7.12,5.4,wD:22.24,24.27,8.8,10.11,(3.3,6.13,;1.81,6.53,;1.41,8.02,;.48,5.76,;-.86,6.53,;-2.19,5.76,;-2.19,4.22,;-3.66,3.75,;-4.56,4.99,;-6.1,4.99,;-3.66,6.24,;-4.43,7.57,;-4.43,2.41,;-3.52,1.17,;-4.43,-.08,;-5.89,.4,;-7.22,-.37,;-7.22,-1.91,;-8.56,.4,;-8.56,1.94,;-7.22,2.71,;-5.89,1.94,;.88,4.27,;2.21,3.5,;1.44,2.17,;1.84,.68,;3.32,.28,;3.72,-1.2,;4.97,-2.11,;4.49,-3.57,;5.26,-4.91,;4.49,-6.24,;5.58,-7.33,;7.07,-6.93,;8.16,-8.02,;7.47,-5.44,;8.56,-6.53,;2.95,-6.24,;2.18,-4.91,;2.95,-3.57,;2.48,-2.11,;.11,2.94,)| | ||
Structure |